Table 5.
Variants | Overall survival | Recurrence-free survival | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Lymph node metastasis (no vs yes) | 1.267 | 0.494–3.249 | 0.622 | 1.185 | 0.639–2.198 | 0.591 |
TNM stage (I/II vs III/IV) | 6.199 | 2.530–15.194 | <0.001 | 3.129 | 1.693–5.785 | <0.001 |
ER (negative vs positive) | 3.780 | 1.361–10.503 | 0.001 | 2.415 | 1.453–4.015 | 0.001 |
LINC01089 (low vs high) | 2.102 | 1.065–4.149 | 0.032 | 1.841 | 1.132–2.994 | 0.014 |
Abbreviations: HR, hazard ratio; CI, confidence interval; ER, estrogen receptor.